Die patofisiologie van Alzheimer se siekte (AD) is 'n komplekse proses wat die opeenhoping van abnormale proteïene, inflammasie en neuroniese disfunksie behels.
Die twee vernaamste kenmerke van AD is die teenwoordigheid van amyloïed-beta (Aβ) plaques en neurofibrillary tangles (NFT's) in die brein.
Amyloïed-beta-plaatjies word gevorm wanneer fragmente van die amyloïedvoorloperproteïen (APP) deur ensieme geskei word om Aβ-peptiede te vorm.
Hierdie peptiede versamel en vorm onoplosbare fibrille wat buite neurone ophoop, wat sel-tot-sel kommunikasie ontwrig en tot neuronale dood lei.
Daar word vermoed dat die opeenhoping van Aβ-plaatjies een van die vroegste gebeure in die ontwikkeling van AD is, en daar word geglo dat dit bydra tot die neurodegeneratiewe proses.
Neurofibrillaire verstrengelings word gevorm wanneer die proteïen tau hiperfosforileer en abnormale filamente binne neurone vorm.
Hierdie klompjies ontwrig die normale funksionering van die mikrotubules, wat noodsaaklik is vir die vervoer van voedingstowwe en ander materiale binne die neuron.
Die verstrengelings lei uiteindelik tot die dood van die aangetaste neurone.
Ontsteking speel ook 'n rol in die patofisiologie van AD.
Die immuunstelsel reageer op die opeenhoping van Aβ-plaques en NFT's deur pro-inflammatoriese sitokiene vry te stel, wat die skade aan neurone kan vererger.
Daarbenewens is daar bewyse dat oksidatiewe stres, mitochondriale disfunksie en verswakte glukosemetabolisme bydra tot die patofisiologie van AD.
Hierdie faktore kan lei tot neuronale disfunksie en dood, wat die siekteproses verder vererger.
Oor die algemeen is die patofisiologie van AD 'n komplekse wisselwerking van verskeie faktore wat uiteindelik lei tot die progressiewe afname in kognitiewe funksie en geheueverlies wat die siekte kenmerk.
Nemeroff CB: The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine. Arch Gen Psychiatry. 1999, 56 (11): 991-2.
Proft J, Weiss N: Jekyll and Hide: The two faces of amyloid β. Commun Integr Biol. 2012, 5 (5): 405-7.
Whitehouse PJ, Hedreen JC, White CL, Price DL: Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol. 1983, 13 (3): 243-8.
Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA, Perry G: Indices of metabolic dysfunction and oxidative stress. Neurochem Res. , 32 (4-5): 717-22.
Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicanò M, Rizzo C, Scapagnini G, Vasto S: Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res. , 13 (2-3): 301-13.
Schindler SE, McConathy J, Ances BM, Diamond MI: Advances in diagnostic testing for Alzheimer disease. Mo Med. , 110 (5): 401-5.
Singh VK: Immune-activation model in Alzheimer disease. Mol Chem Neuropathol. , 28 (1-3): 105-11.
Verwerping van verantwoordelikheid: mediese
Hierdie webwerf word slegs vir opvoedkundige en inligtingsdoeleindes verskaf en vorm nie die verskaffing van mediese advies of professionele dienste nie.
Die inligting wat verskaf word, moet nie gebruik word om 'n gesondheidsprobleem of siekte te diagnoseer of te behandel nie, en diegene wat persoonlike mediese advies soek, moet 'n gelisensieerde dokter raadpleeg.
Let asseblief daarop dat die neurale netwerk wat antwoorde op die vrae genereer, veral onakkuraat is wanneer dit kom by numeriese inhoud. Byvoorbeeld, die aantal mense wat met 'n spesifieke siekte gediagnoseer is.
Soek altyd die advies van jou dokter of ander gekwalifiseerde gesondheidsorgverskaffer oor 'n mediese toestand. Moet nooit professionele mediese advies ignoreer of vertraag om dit te soek as gevolg van iets wat jy op hierdie webwerf gelees het nie. As jy dink jy kan 'n mediese noodgeval hê, bel 911 of gaan onmiddellik na die naaste noodkamer. Geen dokter-pasiënt verhouding word geskep deur hierdie webwerf of die gebruik daarvan nie. Nie BioMedLib of sy werknemers, of enige bydraer tot hierdie webwerf, maak enige voorstellings, uitdruklik of implisiet, met betrekking tot die inligting wat hierin verskaf word of die gebruik daarvan.
Verwerping van verantwoordelikheid: kopiereg
Die Digital Millennium Copyright Act van 1998, 17 U.S.C. § 512 (die DMCA) bied hulp vir kopiereg eienaars wat glo dat materiaal wat op die Internet verskyn, hul regte onder die Amerikaanse kopiereg wet oortree.
As u in goeie trou glo dat enige inhoud of materiaal wat in verband met ons webwerf of dienste beskikbaar gestel word, u kopiereg oortree, kan u (of u agent) vir ons 'n kennisgewing stuur om te versoek dat die inhoud of materiaal verwyder word, of toegang daartoe geblokkeer word.
Kennisgewings moet skriftelik per e-pos gestuur word (sien afdeling "Kontak" vir e-posadres).
Die DMCA vereis dat u kennisgewing van beweerde inbreuk op outeursreg die volgende inligting bevat: (1) beskrywing van die kopieregbeskermde werk wat die onderwerp van beweerde inbreuk is; (2) beskrywing van die beweerde inbreuk op inhoud en inligting wat genoeg is om ons in staat te stel om die inhoud op te spoor; (3) kontakinligting vir u, insluitend u adres, telefoonnommer en e-posadres; (4) 'n verklaring deur u dat u op 'n goeie geloof glo dat die inhoud op die manier waarop u gekla het nie deur die outeursreg eienaar, of sy agent, of deur die werking van enige wet gemagtig is nie;
(5) 'n verklaring deur u, onderteken onder strawwe van meineed, dat die inligting in die kennisgewing akkuraat is en dat u die gesag het om die outeursregte wat beweer word, af te dwing;
en (6) 'n fisiese of elektroniese handtekening van die outeursreg-eienaar of 'n persoon wat gemagtig is om namens die outeursreg-eienaar op te tree.
As u nie al die bogenoemde inligting insluit nie, kan dit lei tot 'n vertraging in die verwerking van u klag.
Kontak
Stuur asseblief vir ons 'n e-pos met enige vrae / voorstelle.
What is pathophysiology of alzheimer?
The pathophysiology of Alzheimer's disease (AD) is a complex process that involves the accumulation of abnormal proteins, inflammation, and neuronal dysfunction.
The two main hallmarks of AD are the presence of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain.
Amyloid-beta plaques are formed when fragments of the amyloid precursor protein (APP) are cleaved by enzymes to form Aβ peptides.
These peptides aggregate and form insoluble fibrils that accumulate outside neurons, disrupting cell-to-cell communication and leading to neuronal death.
The accumulation of Aβ plaques is thought to be one of the earliest events in the development of AD, and it is believed to contribute to the neurodegenerative process.
Neurofibrillary tangles are formed when the protein tau becomes hyperphosphorylated and forms abnormal filaments inside neurons.
These tangles disrupt the normal functioning of the microtubules, which are essential for the transport of nutrients and other materials within the neuron.
The tangles eventually lead to the death of the affected neurons.
Inflammation also plays a role in the pathophysiology of AD.
The immune system responds to the accumulation of Aβ plaques and NFTs by releasing pro-inflammatory cytokines, which can exacerbate the damage to neurons.
Additionally, there is evidence that oxidative stress, mitochondrial dysfunction, and impaired glucose metabolism contribute to the pathophysiology of AD.
These factors can lead to neuronal dysfunction and death, further exacerbating the disease process.
Overall, the pathophysiology of AD is a complex interplay of multiple factors that ultimately lead to the progressive decline in cognitive function and memory loss that characterizes the disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Ongeveer
BioMedLib gebruik outomatiese rekenaars (masjienleeralgoritmes) om vraag-en-antwoord-pare te genereer.
Ons begin met 35 miljoen biomediese publikasies van PubMed/Medline. Ook webbladsye van RefinedWeb.
Sien "Referensies" ook "Verwerping van aanspreeklikheid".
